AngioDynamics posts net loss in Q1

By staff writers

October 6, 2022 -- Interventional technology developer AngioDynamics reported an increase in revenues in the company's first quarter of fiscal 2023, although the firm's net loss grew. The company cited persistent inflation, as well as hospital staffing and procedural pressures, for the loss.

The company's net loss was $13 million for the quarter (end-August 31), compared with a net loss of $7 million in the same period a year ago. However, the company reported strong sales in the first quarter, with an increase of 5.9% to $81.5 million, compared with the same quarter the prior year.

In addition, AngioDynamics said its gross margin was negatively impacted by labor shortages and increased costs for labor, raw materials, and freight. Gross margin for the first quarter of fiscal 2023 was 51.9%, a decrease of 20 basis points compared with the first quarter of fiscal 2022.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking